Business Wire

Cofactor Genomics expands clinical use of OncoPrism, as their AI enabled RNA test achieves ...

ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced today the validation and launch of OncoPrism ®-NSCLC, an ...
Yahoo Finance

Cofactor Genomics Presents Breakthrough Work Combining RNA and AI to bring Precision ...

SAN DIEGO, May 30, 2025--(BUSINESS WIRE)--Cofactor Genomics announced the latest validation results for OncoPrism ®, Cofactor’s breakthrough RNA-based diagnostic approach at the RNA Society’s 30th ...
Business Wire

Cofactor Genomics, Inc. Announces CEO Transition in Preparation for Accelerated Commercial ...

ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, Inc., a commercial-stage company bridging the precision medicine gap by decoding RNA, announced that experienced industry leader Chris Parker has been ...
VentureBeat

Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel ...

Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.